A2. PK/PD studies
Poster Session: PK/PD Studies
Karen Cornelissen, PhD (she/her/hers)
Senior Director, Early Clinical Development
F2G
Manchester, England, United Kingdom
John H. Rex, MD
Chief Medical Officer
F2G, Limited
WELLESLEY HILLS, MA, United States
Daniela Zinzi, MD. Infectious Diseases Specialist (she/her/hers)
Vice President Clinical R&D
F2G
Manchester, England, United Kingdom
Hal Galbraith, PharmaD
IQVIA Inc
Overland Park, Kansas, United States
Howard Burt, PBPK Consultant
Certara UK Ltd (Simcyp Division)
Sheffield, England, United Kingdom